In the past several years, many checkpoint inhibitors have been approved by the FDA for use in treating patients with metastatic bladder cancer. These drugs offer new options for doctors who are treating these patients, but they also pose the challenge of determining the best order in which to use them. Joaquim Bellmunt, MD, Ph.D., […]
Continue readingImmuno-oncology is set to become one of the most vital cancer treatments, rising up into the realms surgery, chemotherapy, radiotherapy, and other targeted therapies. From their study, “Pharma Focus Visual Analysis of Immuno-Oncology Development and Opportunities”, Global Data was able to reach a conclusion and has analyzed more than 4,000 clinical trials of over 800 […]
Continue readingCancer patients have a better chance at beating diseases with the help of immunotherapy, a type of cancer treatment, as studies are now showing. Two new immunotherapy drugs have recently been approved by the Food and Drug Administration last March. One of the immunotherapies approved is Keytruda, which is made to treat Hodgkin’s lymphoma for […]
Continue reading